![]() |
市场调查报告书
商品编码
2009376
医用气体市场规模、份额、趋势和预测:按气体类型、应用、最终用户和地区划分,2026-2034年Medical Gases Market Size, Share, Trends and Forecast by Gas Type, Application, End User, and Region, 2026-2034 |
||||||
2025年全球医用气体市场规模为165亿美元。展望未来,IMARC集团预测,该市场将以5.30%的复合年增长率从2026年增长至2034年,到2034年达到266亿美元。目前,北美市场占据主导地位,预计2025年市占率将超过37.8%。呼吸系统疾病和心血管疾病等慢性病盛行率的上升、医疗技术的进步以及居家医疗和远端医疗的日益普及是推动市场成长的主要因素。
无论是择期手术或急诊手术,麻醉和患者照护通常都需要使用氧气、氧化亚氮和二氧化碳等医用气体。据估计,美国每年约有250万至400万名患者因急诊一般外科手术(EGS)住院。随着外科技术的进步,全球手术量持续成长。这不仅包括传统手术,还包括微创手术(MIS),后者需要特定的气体混合物进行麻醉并维持清晰的手术视野。因此,医院和手术中心高度依赖医用气体来安全有效地进行这些手术。
美国是主要的市场驱动力,占据北美市场85.40%的份额。这主要归因于人口老化加剧,显着增加了手术需求,尤其是与老龄化相关的疾病手术,例如关节重建、白内障手术和心血管手术。据报道,美国每年进行超过400万例白内障手术,且这一数字每年以3-4%的速度成长,预计2030年将达到600万例。此外,择期手术(例如美容手术)的增加也进一步推动了医用气体的需求。同期,美国进行了约2,540万例微创美容手术。随着先进技术和方法的不断发展,手术复杂性不断提高,对麻醉气体和呼吸器气体等特殊气体的需求也不断增长。
呼吸系统疾病和心血管疾病等慢性疾病的发生率增加。
随着慢性阻塞性肺病(COPD)、气喘和间质性肺病等呼吸系统疾病的日益普遍,对氧气等医用气体的需求也随之增长。世界卫生组织(WHO)指出,包括COPD、气喘和间质性肺病在内的慢性慢性阻塞性肺病(CRD)的发生率正在上升。 2019年,光是COPD就导致全球约320万人死亡;根据《世界气喘报告》估计,全球约有2.62亿人患有气喘。氧气疗法对于呼吸困难的患者至关重要,因为它可以维持血液中足够的氧气水平,从而缓解症状。此外,在诊断和治疗心血管疾病(如心臟衰竭、冠状动脉疾病和高血压)时,也经常需要医用气体。在心血管手术中,氧化亚氮被用作麻醉剂,以确保患者的舒适和稳定。医用气体在慢性疾病末期病患的安宁疗护中也不可或缺。
医疗科技的各种进步
技术进步推动了微创手术技术的发展,例如腹腔镜手术和内视镜手术。二氧化碳等医用气体用于改善手术视野,使外科医生能够透过更小的切口进行手术,从而加快患者康復并减少组织损伤。此外,呼吸治疗设备的进步使得呼吸系统疾病的治疗更加精准和个人化。根据世界卫生组织(WHO)统计,慢性呼吸道疾病(CRD),包括慢性阻塞性肺病(COPD)和气喘,在全球呈现上升趋势。 2019年,约有2.62亿人患有气喘,320万人死于COPD。氧气等医用气体透过氧气浓缩机和携带式供氧系统等先进的氧气疗法设备进行输送。此外,冷冻外科和皮肤病学的进步正在拓展液态氮等医用气体的应用范围,用于冷冻和破坏异常或病变组织。冷冻疗法设备能够实现可控和精确的治疗,并最大限度地减少对周围健康组织的损伤,从而推动市场成长。
居家医疗和远端医疗的兴起
在居家医疗中,医用气体(例如氧气)通常在患者家中提供。患有慢性呼吸系统疾病(例如慢性阻塞性肺病 (COPD))的患者需要氧气疗法来控制症状并提高生活品质。居家医疗的趋势增加了对医用氧气的需求,因为患者无需长期住院即可接受氧气疗法。此外,医用气体除了用于氧气疗法外,还有雾化治疗、疼痛管理和呼吸系统治疗等多种用途。这一趋势减少了长期住院的需求,并增加了对医用氧气的需求。此外,据估计,全球每年约有 1,790 万人死于心血管疾病,包括氧气在内的医用气体对于控制相关疾病至关重要,这进一步推动了对居家照护的需求。居家医疗和远端医疗的扩展正在进一步推动对医用气体的需求,因为患者可以在舒适的家中接受更广泛的医用气体治疗。
The global medical gases market size was valued at USD 16.5 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 26.6 Billion by 2034, exhibiting a CAGR of 5.30% during 2026-2034. North America currently dominates the market, holding a market share of over 37.8% in 2025. The rising prevalence of chronic diseases such as respiratory and cardiovascular diseases (CVDs), various advancements in medical technology, and the increasing trend toward home healthcare and telemedicine are some of the major factors propelling the market.
Surgical procedures, both elective and emergency, often require the use of medical gases like oxygen, nitrous oxide, and carbon dioxide for anesthesia and patient care. It is estimated that around 2.5 to 4 million patients are admitted every year in the United States with emergency general surgery (EGS) conditions. As surgical techniques advance, the number of surgeries being performed worldwide continues to rise. This includes not only traditional surgeries but also minimally invasive surgeries (MIS) that require specific gas mixtures for anesthesia and to maintain a clear surgical field. Hospitals and surgical centers, therefore, rely heavily on medical gases to ensure that these procedures are carried out safely and effectively.
The United States stands out as a key market disruptor with a market share of 85.40% in North America. It is driven by the growing geriatric population that is contributing significantly to the demand for surgeries, especially those related to aging issues like joint replacements, cataract removals, and heart surgeries. It has been reported that more than four million cataract surgeries are performed in the United States annually. This number is growing 3-4% each year and is expected to reach six million by the year 2030. Additionally, an increase in elective procedures, such as cosmetic surgeries, is pushing the need for medical gases even further. Nearly 25.4 million cosmetic minimally invasive procedures were performed in the country during the same period. As the complexity of surgeries continues to increase with the development of advanced technologies and techniques, the need for specialized gases, such as anesthetic gases and gases for ventilators, is also on the rise.
Increasing Incidences of Chronic Diseases Such as Respiratory and Cardiovascular Diseases
The growing prevelance of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung diseases, demands medical gases like oxygen for respiratory support. The World Health Organization (WHO) indicates that chronic respiratory diseases (CRDs), which include chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung diseases, are increasing. COPD alone caused approximately 3.2 million deaths worldwide in 2019, and the Global Asthma Report indicates that asthma impacts an estimated 262 million people worldwide. Patients experiencing breathing difficulties require oxygen therapy, which is essential for maintaining adequate oxygen levels in their bloodstream and alleviating symptoms. Besides, cardiovascular disorders, including heart failure, coronary artery disease, and hypertension, often require medical gases for diagnostic purposes and during medical interventions. Nitrous oxide is utilized as an anesthetic agent during cardiovascular surgeries, ensuring patient comfort and stability. Moreover, medical gases are indispensable in providing palliative care to patients with advanced stages of chronic diseases.
Various Advancements in Medical Technology
Technological advancements have led to the development of minimally invasive (MI) surgical procedures, such as laparoscopy and endoscopy. Medical gases like carbon dioxide are used to create a clear operating field, enabling surgeons to perform procedures with smaller incisions, faster patient recovery and reduced tissue trauma. Moreover, advancements in respiratory therapy equipment have enabled more targeted and personalized treatment for respiratory disorders. According to the World Health Organization, chronic respiratory diseases (CRDs), including COPD and asthma, are increasing globally, with approximately 262 million people affected by asthma and 3.2 million deaths attributed to COPD in 2019. Medical gases like oxygen are administered through advanced oxygen therapy devices, including oxygen concentrators and portable oxygen delivery systems. Besides, various advances in cryosurgery and dermatology have expanded the use of medical gases like liquid nitrogen for freezing and destroying abnormal or diseased tissue. Cryotherapy devices offer controlled and targeted treatment, minimizing damage to surrounding healthy tissue, thus propelling the market.
Increasing Trend Toward Home Healthcare and Telemedicine
Home healthcare often involves the provision of medical gases like oxygen to patients in their own residences. Patients with chronic respiratory conditions such as COPD require oxygen therapy to manage their symptoms and improve their quality of life. The trend toward home healthcare allows patients to receive oxygen therapy without the need for prolonged hospital stays, leading to increased demand for medical oxygen gases. Moreover, medical gases have various applications beyond oxygen therapy, such as nebulization, pain management, and respiratory treatments. This trend reduces the need for prolonged hospital stays, increasing the demand for medical oxygen. Furthermore, with an estimated 17.9 million global deaths from cardiovascular diseases annually, medical gases, including oxygen, are also vital for managing related conditions, enhancing the demand for home treatments. The expansion of home healthcare and telemedicine allows patients to receive a wider range of medical gas treatments in the comfort of their homes, further driving the demand for medical gases.
Pure gases (medical oxygen) lead the market with around 57.8% of market share in 2025. Pure gases are essential for medical applications that require precise concentrations and accurate dosages. Medical procedures such as diagnostic testing, anesthesia, amnd respiratory therapy, necessitate gases with consistent and known compositions to achieve reliable results. Moreover, many medical procedures require a controlled environment to achieve desired outcomes. Pure gases provide the necessary control over variables like gas composition and pressure, ensuring optimal conditions for treatments, surgeries, and therapies. Besides, medical equipment and devices are calibrated and designed to work with specific gas compositions. Pure gases maintain the integrity of medical equipment and help prevent malfunctions that could impact patient care.
Therapeutic leads the market with around 42.4% of market share in 2025. Medical gases, especially oxygen, are extensively used to manage respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and respiratory distress syndrome. Therapeutic oxygen delivery supports patients with compromised breathing and improves their quality of life. Besides, medical gases are indispensable in critical care units and emergency settings. They are administered to stabilize patients with acute respiratory distress, trauma, cardiac arrest, and other life-threatening conditions, playing a pivotal role in preventing further complications. Moreover, these gases are integrated into various rehabilitation and physiotherapy programs. They assist patients recovering from injuries, surgeries, or neurological disorders, aiding in improved breathing and overall well-being.
Hospitals leads the market with around 29.8% of market share in 2025. Hospitals provide a wide range of medical services, including surgeries, emergency care, critical care, diagnostics, and treatments. Medical gases are utilized extensively in these diverse medical applications, such as anesthesia during surgeries, oxygen therapy for patients with respiratory conditions, and medical gas mixtures for diagnostic procedures. Moreover, hospitals perform a multitude of surgical procedures, ranging from routine surgeries to complex operations. Medical gases like oxygen and anesthetic gases are crucial for ensuring patient safety, comfort, and successful outcomes during surgical interventions. Besides, diagnostic imaging procedures, such as magnetic resonance imaging (MRI) and computed tomography (CT) scans, often involve the use of medical gases. These gases can be used to create contrast agents for enhanced imaging accuracy.
In 2025, North America accounted for the largest market share of over 37.8%. North America boasts advanced healthcare infrastructure, including well-established hospitals, clinics, research centers, and medical facilities. This robust infrastructure creates a high demand for medical gases for various medical procedures, surgeries, diagnostics, and patient care. Moreover, the region is a hub for medical research and technological innovation. Technological advancements in medical treatments, procedures, and diagnostic tools often require specialized medical gases for accurate diagnostics and efficient interventions, further driving the demand for these gases. Besides, the high prevalence of chronic diseases in North America, such as respiratory disorders, cardiovascular diseases, and diabetes, drives the demand for medical gases for treatments, therapies, and life support systems.
UNITED STATES MEDICAL GAS MARKET ANALYSIS
The U.S. is leading the market in North America with over 85.40% market share. The U.S. medical gases market is booming with the advancement in health care and increased demand both in hospitals and home care settings. According to American Hospital Association, more than 33 million inpatient admissions took place in 2022, which has escalated the demand for oxygen and anesthetic gases. Other key drivers include the home healthcare market, furthered by the widespread adoption of portable oxygen concentrators. As indicated by the National Institute on Aging, around 15 million Americans have a need for respiratory treatments. Major companies such as Air Products and Praxair focus on innovation and sustainability to gain market power. An improved healthcare infrastructure with emergency preparedness from the U.S. government increases market demand. Strong partnerships between the manufacturers and health providers expand access to important medical gases. Enhanced regulation ensures safe and quality productions, further stabilizing the market to grow. Export of U.S.-produced gases to international markets also adds to its dominance.
EUROPE MEDICAL GAS MARKET ANALYSIS
European medical gases are growing by technology advancement and an age of people needing respiratory care. As many as over 100 million Europeans suffer from chronic respiratory diseases, thereby creating more demand for oxygen therapy; and market consumption in Germany, France, and the UK is dominating as the countries have advanced health systems with a higher prevalence rate of the diseases. According to the German Federal Statistical Office, health-care spending in Germany stood at EUR 489 billion (USD 491.8) in 2022, thereby continuously investing into resources like medical gases, and green initiatives are developed and adopted by adopting eco-friendly cylinders made of gas and sustainable modes of production. Air Liquide and Linde are leading-edge innovation providers with substantial research investments into enhancing product performance and efficiency. The collaboration between governments and private entities ensures wide accessibility and high quality.
ASIA PACIFIC MEDICAL GAS MARKET ANALYSIS
Asia Pacific's medical gases market is highly growing with rising healthcare investment and the burden of disease. According to the World Bank, healthcare spending in China has increased to USD 1.2 Trillion by 2022, thus supporting the modernization of infrastructures and the use of advanced gas delivery systems. In India, the National Health Mission spends considerable sums on oxygen supply, especially to rural regions, hence increasing wider accessibility. According to Financial Express news article, India has allocated a 12% increase in healthcare budget for 2023, a proof of commitment towards health reform from the government side. Taiyo Nippon Sanso, one of the leading companies, with the support of local entities, develops cheaper solutions. Demand for specialty gases also rises as with the growth in demand for nitric oxide in neonatal care. Regulations toward quality assurance and safety add value to this growth.
LATIN AMERICA MEDICAL GAS MARKET ANALYSIS
The Latin American medical gases market is gradually growing with the rise in healthcare access and improvement in medical technologies. As reported by an industrial report, the healthcare expenditure of Brazil constituted 13% of GDP in 2022, which further enhances the demand for essential gases like oxygen and nitrous oxide. Demand from medical tourism in countries like Costa Rica and Mexico is also boosting demand, as hospitals seek to acquire advanced equipment and gases to attract international patients. According to an article, more than 20% of Latin Americans are afflicted with respiratory diseases, which further fuels demand for therapeutic gases. Local players such as Indura S.A. collaborate with global companies to enhance production capacity and facilitate technology transfer. Government-supported schemes, such as subsidies for the rural health centers, promote wider use of medical gases.
MIDDLE EAST AND AFRICA MEDICAL GAS MARKET ANALYSIS
The Middle East and Africa medical gases market is growing by increasing healthcare infrastructure development and further rising disease burden. In 2022, as reported by the International Trade Administration, Saudi Arabia allocated more than USD 50 Billion to healthcare, directed toward advanced hospital infrastructure and acute care units. Oxygen therapy demand increased in Africa because respiratory diseases such as pneumonia remain at the top of the mortalities list. Regional companies, like African Oxygen Limited (Afrox) engage with international companies to increase their production scale and fulfil regional demands. By building hospitals and healthcare facilities, governments like that of Saudi Vision 2030 enhance modernization, and medical gases consumption increases.
The competitive landscape of the market is characterized by the presence of multiple players that include emerging startups, established brands, and specialty manufacturers. Presently, leading companies are focusing on innovating their medical gas offerings by introducing advanced gas mixtures, specialized formulations, and new delivery methods to cater to evolving medical needs and treatment modalities. They are also forming strategic partnerships with healthcare providers, hospitals, clinics, and research institutions to establish a strong network and secure long-term contracts. Besides, companies are expanding their market presence through geographical expansion, entering emerging markets with growing healthcare infrastructure, and establishing new distribution channels to reach a wider customer base.